Medical Comorbidity & C-L Psychiatry at AAAP 37th Annual Meeting and Scientific Symposium
5 sessions on medical comorbidity & c-l psychiatry · November 12–15, 2026, Memphis, TN. Compare medical comorbidity & c-l psychiatry at other meetings →
Friday, November 13
10:40–12:10 · Session · Case Conference
An ICD for Harm Reduction: Methadone-Associated Torsades de Pointes in a Patient With Opioid Use Disorder
Case of a man with opioid use disorder who developed torsades de pointes on methadone and other QT-prolonging exposures. Discusses withdrawal management, methadone retitration, and the decision to place a subcutaneous ICD as a harm reduction measure.
Sunday, November 15
Posters (4)
- Bone Health Outcomes Among Patients with Opioid Use Disorder: Buprenorphine vs. Methadone Across Two Complementary Analyses — Claire Drotman
- Hidden in Plain Sight: Cocaine Induced Midline Destructive Lesions Misdiagnosed as Granulomatosis with Polyangiitis in a High Functioning Patient with 40 Years of Concealed Cocaine Use — Angelica DiLorenzo
- When Psychiatry Changes the Stroke Workup: Nitrous Oxide Associated Mixed Arterial and Venous Thrombosis Presenting as Recurrent Stroke and Central Auditory Dysfunction — Mashal Jamil
- Psychosis or Encephalopathy? Addiction Psychiatry Challenges in Co-Occurring Schizophrenia, Alcohol Use Disorder, and Decompensated Liver Disease — Fnu Shashi Kant
Other topics at this meeting
Substance Use Disorders 87Opioid Use Disorder 48Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Emergency & Acute Psychiatry 11Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8